NCT02848651: A reported trial by Genentech, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02848651 |
|---|---|
| Title | A Phase II Single-Arm Study of Atezolizumab Monotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Clinical Evaluation of Novel Blood-Based Diagnostics |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Sept. 23, 2016 |
| Completion date | May 14, 2019 |
| Required reporting date | May 14, 2020, midnight |
| Actual reporting date | April 15, 2020 |
| Date last checked at ClinicalTrials.gov | May 20, 2025 |
| Days late | None |